Thomas L Rosch - Net Worth and Insider Trading

Thomas L Rosch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas L Rosch owns 4 companies in total, including Tesaro Inc (TSRO) , Paratek Pharmaceuticals Inc (PRTK) , and Metabasis Therapeutics Inc (LGNZZ) among others .

Click here to see the complete history of Thomas L Rosch’s form 4 insider trades.

Insider Ownership Summary of Thomas L Rosch

Ticker	Company	Transaction Date	Type of Owner
TSRO	Tesaro Inc	2012-07-03	10 percent owner
PRTK	Paratek Pharmaceuticals Inc	2011-09-20	10 percent owner
LGNZZ	Metabasis Therapeutics Inc	2008-04-16	10 percent owner
		2007-11-20	10 percent owner

Thomas L Rosch Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas L Rosch Ownership Network

Ownership Network List of Thomas L Rosch

No Data

Ownership Network Relation of Thomas L Rosch

Thomas L Rosch Owned Company Details

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Thomas L Rosch is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include SVP & Chief Medical Officer Huber Martin H. Jr. , 10 percent owner New Enterprise Associates 13 Lp , and 10 percent owner Nea 13 Gp, Ltd .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Thomas L Rosch is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Metabasis Therapeutics Inc do?

Who are the key executives at Metabasis Therapeutics Inc?

Thomas L Rosch is the 10 percent owner of Metabasis Therapeutics Inc. Other key executives at Metabasis Therapeutics Inc include 10 percent owner Ansbert Gadicke , 10 percent owner Michael Steinmetz , and 10 percent owner Mpm Asset Management Investors 2000b Llc .

Metabasis Therapeutics Inc (LGNZZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metabasis Therapeutics Inc (LGNZZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metabasis Therapeutics Inc (LGNZZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metabasis Therapeutics Inc (LGNZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metabasis Therapeutics Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Thomas L Rosch is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

Thomas L Rosch Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas L Rosch. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Thomas L Rosch's mailing address is: Menlo Park Ca 94025.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.